New insider Fields Isaiah claimed ownership of 57,588 shares (SEC Form 3)
$AXON
Ordnance And Accessories
Industrials
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 01/01/2026 |
3. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 57,588.31 | D(1)(2)(3) | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Explanation of Responses: |
| 1. Includes 16,001.31 restricted stock units subject to vesting conditions related to four separate time-vested awards granted to the reporting person pursuant to the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan. The grants will vest 1,782 shares on March 3, 2026, 1,781 shares on each of May 31, 2026, August 31, 2026, and November 30, 2026, 1,238 shares on each of March 3, 2027, May 31, 2027, August 31, 2027, and November 30, 2027, 981.08 shares on each of March 3, 2028, May 31, 2028, and August 31, 2028, and 981.07 shares on November 30, 2028. |
| 2. Includes 10,488 performance-based restricted stock units granted on December 22, 2023, for the achievement of tranche 3 of the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions were certified by the Compensation Committee on November 13, 2025 as having been met. The restricted stock units will vest on June 1, 2026, subject to continued employment through such date. Following the vesting, the shares are subject to a minimum holding period from the vesting date until the earlier of (i) December 31, 2030 and (ii) the date that a subsequent tranche vests, excluding shares that are withheld or sold to cover taxes. |
| 3. Includes 31,099 shares issued upon the release of time-vested restricted stock units and performance-based restricted stock units prior to January 1, 2026 |
| Remarks: |
| Isaiah Fields | 01/12/2026 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||